What's in Caliway Biopharmaceuticals Co., Ltd.'s pipeline?

Caliway Biopharmaceuticals Co., Ltd. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Caliway Biopharmaceuticals Co., Ltd.'s portfolio?

Top competitors by shared drug class: Bayer, Beta Pharma Shanghai, Betta Pharmaceuticals Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Eisai Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/caliway-biopharmaceuticals-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Caliway Biopharmaceuticals Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Caliway Biopharmaceuticals Co., Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
CBL-514	CBL-514	phase 3	FGFR inhibitor	FGFR (Fibroblast Growth Factor Receptor)	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 1 shared drug class
Beta Pharma Shanghai · 1 shared drug class
Betta Pharmaceuticals Co., Ltd. · 1 shared drug class
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 1 shared drug class
Eisai Inc. · 1 shared drug class
Eli Lilly and Company · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Allist Pharmaceuticals, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Caliway Biopharmaceuticals Co., Ltd.:

Cite this brief

Drug Landscape (2026). Caliway Biopharmaceuticals Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/caliway-biopharmaceuticals-co-ltd. Accessed 2026-05-16.